ICU vs. EDAP, BDMD, NTRB, APYX, VANI, LUNG, QTI, ICCM, TELA, and SURG
Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include EDAP TMS (EDAP), Baird Medical Investment (BDMD), Nutriband (NTRB), Apyx Medical (APYX), Vivani Medical (VANI), Pulmonx (LUNG), QT Imaging (QTI), IceCure Medical (ICCM), TELA Bio (TELA), and SurgePays (SURG). These companies are all part of the "medical equipment" industry.
SeaStar Medical vs. Its Competitors
SeaStar Medical (NASDAQ:ICU) and Edap Tms (NASDAQ:EDAP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.
SeaStar Medical has a beta of -1, suggesting that its stock price is 200% less volatile than the S&P 500. Comparatively, Edap Tms has a beta of -0.21, suggesting that its stock price is 121% less volatile than the S&P 500.
Edap Tms has higher revenue and earnings than SeaStar Medical. Edap Tms is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, SeaStar Medical and SeaStar Medical both had 1 articles in the media. Edap Tms' average media sentiment score of 0.34 beat SeaStar Medical's score of 0.00 indicating that Edap Tms is being referred to more favorably in the news media.
1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 62.7% of Edap Tms shares are owned by institutional investors. 1.3% of SeaStar Medical shares are owned by company insiders. Comparatively, 0.2% of Edap Tms shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Edap Tms has a net margin of -33.49% compared to SeaStar Medical's net margin of -1,915.27%. SeaStar Medical's return on equity of 0.00% beat Edap Tms' return on equity.
Edap Tms has a consensus target price of $8.50, indicating a potential upside of 251.24%. Given Edap Tms' stronger consensus rating and higher probable upside, analysts clearly believe Edap Tms is more favorable than SeaStar Medical.
Summary
Edap Tms beats SeaStar Medical on 11 of the 15 factors compared between the two stocks.
Get SeaStar Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SeaStar Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICU) was last updated on 9/23/2025 by MarketBeat.com Staff
